$SGEN News Article - Astellas and Seattle Genetics
Post# of 74
(Total Views: 348)
Posted On: 09/18/2020 3:40:48 PM
$SGEN News Article - Astellas and Seattle Genetics Announce PADCEV (enfortumab vedotin-ejfv) Significantly Improved Overall Survival in Phase 3 Trial in Previously Treated Locally Advanced or Metastatic Urothelial Cancer https://marketwirenews.com/news-releases/aste...24363.html
(0)
(0)Seattle Genetics Inc. (SGEN) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼